These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1143 related items for PubMed ID: 26027813
1. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease. Kim CM, Hwang J, Lee JM, Roh JH, Lee JH, Koh JY, Alzheimer’s Disease Neuroimaging Initiative (ADNI). Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813 [Abstract] [Full Text] [Related]
4. Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction. Hatashita S, Yamasaki H. PLoS One; 2013; 8(6):e66877. PubMed ID: 23799136 [Abstract] [Full Text] [Related]
5. Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer's disease. Guo T, Li A, Sun P, He Z, Cai Y, Lan G, Liu L, Li J, Yang J, Zhu Y, Zhao R, Chen X, Shi D, Liu Z, Wang Q, Xu L, Zhou L, Ran P, Wang X, Sun K, Lu J, Han Y. Mol Neurodegener; 2024 Jul 30; 19(1):58. PubMed ID: 39080744 [Abstract] [Full Text] [Related]
6. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, Lopresti BJ, Ziolko S, Bi W, Paljug WR, Debnath ML, Hope CE, Isanski BA, Hamilton RL, DeKosky ST. Brain; 2008 Jun 30; 131(Pt 6):1630-45. PubMed ID: 18339640 [Abstract] [Full Text] [Related]
10. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects. Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Matsuoka K, Takahashi M, Nakagawara J, Iida H, Kishimoto T, Nagatsuka K. Neuroimage Clin; 2017 Jun 30; 13():209-214. PubMed ID: 28003959 [Abstract] [Full Text] [Related]
11. Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease. Zhang J, Chen H, Wang J, Huang Q, Xu X, Wang W, Xu W, Guan Y, Liu J, Wardlaw JM, Deng Y, Xie F, Li B. Alzheimers Dement; 2024 Jun 30; 20(6):3931-3942. PubMed ID: 38648354 [Abstract] [Full Text] [Related]
12. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease. Ossenkoppele R, Smith R, Ohlsson T, Strandberg O, Mattsson N, Insel PS, Palmqvist S, Hansson O. Neurology; 2019 Feb 05; 92(6):e601-e612. PubMed ID: 30626656 [Abstract] [Full Text] [Related]
15. Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease. Cody KA, Langhough RE, Zammit MD, Clark L, Chin N, Christian BT, Betthauser TJ, Johnson SC. Brain; 2024 Jun 03; 147(6):2144-2157. PubMed ID: 38667631 [Abstract] [Full Text] [Related]
18. Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging. Hatashita S, Wakebe D. J Alzheimers Dis; 2017 Jun 03; 57(3):765-773. PubMed ID: 28304292 [Abstract] [Full Text] [Related]
19. Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness. Hani Hojjati S, Butler TA, Chiang GC, Habeck C, RoyChoudhury A, Feiz F, Shteingart J, Nayak S, Ozoria S, Fernández A, Stern Y, Luchsinger JA, Devanand DP, Razlighi QR. Neuroimage Clin; 2023 Jun 03; 38():103409. PubMed ID: 37104927 [Abstract] [Full Text] [Related]